BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8009505)

  • 21. [The role of hyperinsulinemia in the immunopathogenesis of atherosclerosis in diabetics].
    Krasil'nikova EI; Freĭdlin IS
    Patol Fiziol Eksp Ter; 1991; (4):41-3. PubMed ID: 1798652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The study of development and progression of long-term complications in type I diabetes].
    Araki E; Matsumura T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():134-9. PubMed ID: 12386984
    [No Abstract]   [Full Text] [Related]  

  • 23. Intensive insulin treatment in diabetic children.
    Ludvigsson J; Bolli GB
    Diabetes Nutr Metab; 2001 Oct; 14(5):292-304. PubMed ID: 11806471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological aspects of diabetic angiopathies pathogenesis].
    Galenok VA; Zhuk EA
    Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794
    [No Abstract]   [Full Text] [Related]  

  • 25. Study: tight glucose control in diabetes lowers risk of atherosclerosis.
    FDA Consum; 2003; 37(4):10. PubMed ID: 12971340
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Hirsch IB; Brownlee M
    Diabetes Care; 2007 Jan; 30(1):186-7; author reply 188-9. PubMed ID: 17192365
    [No Abstract]   [Full Text] [Related]  

  • 27. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation for surgery of an insulin-dependent diabetic patient].
    Manunta A; Di Saverio G; Bergamaschi R; Enea D; Camilleri G; Giani L
    Minerva Chir; 1988 Sep; 43(17):1377-80. PubMed ID: 3062494
    [No Abstract]   [Full Text] [Related]  

  • 29. [Functional insulin therapy in the type 1 diabetic].
    Grimm JJ; Hegar K; Berger W
    Journ Annu Diabetol Hotel Dieu; 2000; ():145-54. PubMed ID: 10932877
    [No Abstract]   [Full Text] [Related]  

  • 30. Long term complications of IDDM and intensified insulin treatment.
    Misra A
    Natl Med J India; 1994; 7(4):174-5. PubMed ID: 7950951
    [No Abstract]   [Full Text] [Related]  

  • 31. Normoglycaemic re-entry and diabetic complications.
    Keen H
    Diabet Med; 1984 Jul; 1(2):85-7. PubMed ID: 6242792
    [No Abstract]   [Full Text] [Related]  

  • 32. A semiclosed-loop optimal control system for blood glucose level in diabetics.
    Ibbini MS; Masadeh MA; Amer MM
    J Med Eng Technol; 2004; 28(5):189-96. PubMed ID: 15370997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin-substitute therapy in diabetes mellitus].
    Genes SG
    Ter Arkh; 1977; 49(12):126-31. PubMed ID: 341400
    [No Abstract]   [Full Text] [Related]  

  • 34. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of diabetes mellitus and its complications. 7. Control of blood glucose and diabetic microangiopathy].
    Shichiri M
    Nihon Naika Gakkai Zasshi; 1996 Sep; 85(9):1484-9. PubMed ID: 8999095
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The important 3:00 am blood glucose.
    Hirsch RF; Hirsch IB
    Am J Nurs; 1988 Aug; 88(8):1070. PubMed ID: 3041836
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing diabetes: a major study injects good news.
    Robertson C; Cerrato PL
    RN; 1993 Oct; 56(10):26-9. PubMed ID: 8235312
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic considerations in the treatment of juvenile diabetes mellitus.
    Bacon GE; Parkhurst RD
    Med Clin North Am; 1969 Nov; 53(6):1367-78. PubMed ID: 4982939
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intensified treatment of diabetes mellitus and prevention of the development or progression of complications].
    Kawamori R
    Nihon Naika Gakkai Zasshi; 1997 Mar; 86(3):358-64. PubMed ID: 9198611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.